Artificial Intelligence Based Models for Primary Sjögren's Syndrome Diagnosis
NCT06982482 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 27432
Last updated 2025-05-21
Summary
The goal of this observational study is to develop and validate artificial intelligence (AI)-driven models for improving the diagnosis of Primary Sjögren's Syndrome (PSS) using routine laboratory test data. The main question it aims to answer is:
Can AI-based algorithms accurately diagnose Primary Sjögren's Syndrome by analyzing laboratory test results, and do they outperform traditional diagnostic criteria in Chinese populations?
Researchers will retrospectively analyze anonymized clinical records and laboratory data (e.g., autoantibody levels, inflammatory markers) from patients with suspected or confirmed PSS across multiple medical centers in China. No new interventions will be administered, as the study utilizes existing historical data to train and validate the AI models. The performance of AI algorithms will be compared with current diagnostic standards (e.g., ACR/EULAR criteria) in terms of sensitivity, specificity, and clinical utility.
Conditions
- Primary Sjögren's Syndrome (pSS)
Sponsors & Collaborators
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
lead OTHER
Principal Investigators
-
Xinran Yuan, MD · Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-01-01
- Primary Completion
- 2023-01-01
- Completion
- 2025-01-01
Countries
- China
Study Locations
More Related Trials
-
A Study of INCB050465 in Primary Sjögren's Syndrome
NCT03627065 ·Status: COMPLETED ·Phase: PHASE2
-
A Prospective Cohort Study of Myasthenia Gravis in China
NCT06006832 ·Status: RECRUITING
-
A Phase 2a, Randomized, Placebo Controlled, Study to Evaluate the Safety and Efficacy of AMG 557/MEDI5872 in Primary Sjögren's Syndrome
NCT02334306 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Safety and Effectiveness of Efgartigimod in Patients With Primary Sjögren's Syndrome (pSS)
NCT05817669 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS)
NCT04968912 ·Status: COMPLETED ·Phase: PHASE2
-
Vaccine Coverage and Primary Sjögren'Syndrome
NCT04224454 ·Status: COMPLETED
-
Biomarkers in Autoimmune Disease of Nervous System
NCT06502015 ·Status: RECRUITING
-
Evaluate the Efficacy of Anti-Jak1 Inhibitors as Treatment for Patients With Aicardi-Goutières Syndrome
NCT06898372 ·Status: COMPLETED
-
Anti-Argonaute Antibodies for the Diagnosis of Sensory Neuronopathies
NCT05966350 ·Status: COMPLETED
-
A Study of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Primary Sjögren's Syndrome
NCT04078386 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of Iguratimod Compared to Placebo in Patients With Active Primary Sjogren's Syndrome.
NCT04830644 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety of Triple Therapy in Patients With Anti-MDA5 Antibody-positive Dermatomyositis
NCT05375435 ·Status: UNKNOWN ·Phase: PHASE4
-
JY231 Injection for the Treatment of Relapsed/Refractory Neurologic Immune Disorders
NCT06797024 ·Status: RECRUITING ·Phase: NA
-
Intravenous Immunoglobulins for the Treatment of Primary Sjögren's Syndrome Associated Painful Sensory Neuropathies
NCT03700138 ·Status: COMPLETED ·Phase: PHASE3
-
Slow vs. Rapid Glucocorticoids Tapering With Inebilizumab in NMOSD
NCT07132398 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Inectolizumab With Steroid Optimization in Newly Treated NMOSD
NCT07159893 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
TheRapeutic Effect of Different immunosuppressAnts on Non-Thymoma Ocular Myasthenia Gravis: a Real-world Study
NCT04182984 ·Status: RECRUITING
-
An Diagnostic Cohort on AQP4-Immunoglobulin G Detection Kit
NCT04388072 ·Status: COMPLETED
-
Investigating the Morbidity of Glucocorticoid Use in Patients With Autoimmune Bullous Diseases (AIBDs)
NCT05525065 ·Status: UNKNOWN
-
Tocilizumab vs Azathioprine in Neuromyelitis Optica Spectrum Disorders
NCT03350633 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Application of Artificial Intelligence in Precision Medicine and Healthcare
NCT06879210 ·Status: RECRUITING ·Phase: NA
-
Detecting Fatigue From Voice in Generalised Myasthenia Gravis
NCT07033559 ·Status: NOT_YET_RECRUITING
-
Clinical Study of CM338 in the Treatment of Immunoglobulin A Nephropathy
NCT05775042 ·Status: RECRUITING ·Phase: PHASE2
-
Tongji NADs Cohort
NCT07333196 ·Status: NOT_YET_RECRUITING
-
Detection and Characterization of Neurologic Manifestations of Inborn and Acquired Errors of Immunity
NCT06169150 ·Status: RECRUITING